# Brenig

**Canonical:** https://apis.io/providers/brenig/  
**Website:** https://www.brenigther.com/  
**APIs profiled:** 0

Brenig Therapeutics is a biotechnology company that develops small‑molecule therapies for neurodegenerative diseases, focusing on Parkinson’s disease. It creates brain‑penetrant inhibitors such as BT‑267 targeting LRRK2 and BT‑409 targeting NLRP3, using AI‑driven drug discovery to design selective compounds for disease‑modifying treatment.

## Kin Score — 9.0 / 100 (minimal)

Scored 2026-10-31 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 21.1 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 13.7 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Brenig Domain Security** — TLSv1.3

## Tags

Biotechnology, Neurodegenerative Diseases, Parkinson's Disease, Small‑Molecule Therapeutics, AI‑Driven Drug Discovery

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/brenig/). Scores are computed from the provider's own public artifacts under a published rubric.